Trastuzumab M22143
The add to cart button will appear once you select the values above
Specifications
| inquiry |
CAS Number:
180288-69-1
Target:
HER2
Molecular formula:
——
Formula weight:
146 kDa
Purity:
>98% (HPLC)
Stability:
≥ 2 years
Product description:
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Note:
Research use only, not for human use.
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com